Creatine in women: what the evidence says and what it does not
What is known about creatine in women: safety measured in 951 participants, the gap where only 9% of studies qualify, and which other effects are unproven.
If creatine is the best-studied supplement in the world and almost everything we know comes from men, the obvious question is what happens with women. The short answer: there is a good deal less evidence, and where it exists, it is reassuring on safety. The long answer is more interesting.
This article does not replace the blog’s general creatine page, which explains the mechanism and the figures in the general population. This is about what is specific to women, and about what cannot be said.
The starting fact: there are almost no studies in women
Before any conclusion, a systematic review and safety meta-analysis did the counting work [3]. Of 656 studies identified in which creatine supplementation was the main intervention, only 58 were women-only, that is 9 % [3].
And of those, only 29 monitored adverse outcomes, with 951 participants [3]. The rest did not look. That 9 % is the number to keep in mind every time you read a claim about creatine. The evidence on safety in women exists; the evidence on efficacy in women is much scarcer.
What the 29 studies that did monitor found
The meta-analysis results, in supplemented women versus controls [3]:
| Outcome | Estimated effect | Reading |
|---|---|---|
| Deaths or serious adverse events | None | No alarm signal |
| Total adverse events | RR 1.24 (CI 0.51-2.98) | No significant difference |
| Gastrointestinal events | RR 1.09 (CI 0.53-2.24) | No significant difference |
| Weight gain | MD 1.24 kg (CI -0.34 to 2.82) | No significant difference |
| Kidney or liver function | No significant differences | Nothing to flag |
The confidence intervals are wide and all cross 1 or 0, so the correct reading is “no difference was detected”, not “a difference was ruled out”. That distinction matters, and the authors’ conclusion respects it: they recommend that future studies monitor and report adverse effects so we can inform people better [3].
On efficacy: what can be said and what cannot
Here it pays to be disciplined, because this is where the conversation runs away from the evidence.
What the position stand of the International Society of Sports Nutrition [1] says is that creatine increases muscle availability of creatine and phosphocreatine, and that this “may therefore improve acute exercise capacity and adaptations to training”, with improvements of 10 % to 20 % in high intensity or repetitive exercise after a loading phase [1]. That claim does not distinguish between sexes: it is the base of the evidence, which comes mostly from men.
On hypertrophy, the 2023 meta-analysis that only includes studies with imaging in healthy adults found a small effect, with a standardized mean difference of 0.11 whose credible interval includes zero [2]. And here comes the figure that matters for this article: of the trials analyzed, only one included women alone [2].
In other words: with the best available evidence on hypertrophy, the answer to “does creatine work the same in women?” is “we do not know well”. It is not that there is evidence it does not work; it is that it has barely been studied.
The only group with a signal of its own: older women
There is one result that really is specific to women, and it comes from a systematic review of 17 randomized trials of creatine plus training in older adults [4].
Its conclusion about the mechanism is cautious: the possible additive effects of creatine on strength, functional capacity or lean mass in older population would require continuous, daily supplementation at a low dose and at least 12 weeks of strength training [4]. On regional femoral bone density, the review notes it might require at least a year of supplementation combined with moderate resistance, and that long-term clinical trials are needed [4].
And here is the finding that justifies an article of its own: the beneficial effects of creatine are more consistent in older women than in men [4].
Worth reading calmly, because “more consistent” in a review of small trials does not mean “proven in women”. It means that when you look at trials in older people, the signal shows up in women more often than in men. It is an indication, not a conclusion.
Where the line sits: pregnancy and who to ask
The answer to the question “is creatine safe for a woman?” depends on what point in life you are asking about.
The position stand [1] defines its population as healthy people and people with disease, and mentions pregnancy among the clinical applications studied [1], without establishing a recommendation for use. The safety reviews in the collection address the kidney, not pregnancy.
The cautious and honest answer: if you are pregnant, breastfeeding or postpartum, the decision is medical. It is not a recommendation of this article, it is the absence of evidence that makes the question one for your healthcare professional. And in case of kidney disease, the same applies.
In summary
- Only 9 % of the 656 studies on creatine were women-only, and only 29 monitored adverse effects, with 951 participants [3].
- In those studies there were no deaths or serious adverse events, nor significant differences in total, gastrointestinal events, weight, or kidney and liver function [3]; the intervals cross the null, so this is “not detected”, not “ruled out”.
- The ISSN position stand reports improvements of 10-20 % in high intensity [1], but that evidence comes mostly from men.
- On hypertrophy measured by imaging, the effect is small and its credible interval includes zero, and only one trial included women alone [2]: efficacy in women is poorly measured.
- In older population, the effects of creatine are more consistent in women than in men, and would require at least 12 weeks of supplementation plus strength training [4]. It is an indication, not a demonstration. None of this is a recommendation to take creatine. It is what the evidence says, with its effect size and its gaps, so that each person can decide. If you are pregnant, breastfeeding, postpartum or you have kidney disease, the decision belongs to your healthcare professional.
For the rest of the section, the practical strength guide covers programming, and there are two earlier articles in this section worth keeping at hand: strength training in pregnancy and strength training in menopause.
Related articles
Sources for this article (4) 4 references
- Kreider RB, Kalman DS, Antonio J, et al. (2017) International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition 14:18. See source (opens in a new tab) DOI: 10.1186/s12970-017-0173-z Position Stand de la ISSN sobre creatina (revisión narrativa, no metaanálisis) Licence: Artículo de acceso abierto (BMC/Springer, CC BY 4.0). Se cita con enlace. Consulted:
- Burke R, Piñero A, Coleman M, et al. (2023) The Effects of Creatine Supplementation Combined with Resistance Training on Regional Measures of Muscle Hypertrophy: A Systematic Review with Meta-Analysis. Nutrients 15(9):2116. See source (opens in a new tab) DOI: 10.3390/nu15092116 Revisión sistemática y metaanálisis (10 estudios, ≥6 semanas,RM/TC/US): efecto muy pequeño de la creatina sobre hipertrofia medida por imagen Licence: Artículo de acceso abierto en PMC (MDPI, CC BY 4.0). Se cita con enlace. Consulted:
- de Guingand DL, Palmer KR, Snow RJ, Davies-Tuck ML, Ellery SJ (2020) Risk of Adverse Outcomes in Females Taking Oral Creatine Monohydrate: A Systematic Review and Meta-Analysis. Nutrients 12(6):1780. See source (opens in a new tab) DOI: 10.3390/nu12061780 Revisión sistemática y metaanálisis de seguridad de la creatina en mujeres: de 656 estudios identificados, solo el 9 % eran de solo mujeres y 29 monitorizaron resultados adversos (951 participantes) Licence: Artículo de acceso abierto en PubMed Central (MDPI, CC BY 4.0). Se cita con enlace. Consulted:
- Stares A, Bains M (2020) The Additive Effects of Creatine Supplementation and Exercise Training in an Aging Population: A Systematic Review of Randomized Controlled Trials. J Geriatr Phys Ther 43(2):99-112. See source (opens in a new tab) DOI: 10.1519/JPT.0000000000000222 Revisión sistemática de 17 ensayos aleatorizados sobre la combinación de creatina y entrenamiento en adultos mayores; los efectos beneficiosos de la creatina serían más consistentes en mujeres mayores que en hombres Licence: Artículo de revista con derechos de autor. Se cita con enlace al editor; no se reproduce texto salvo cita breve verificable. Consulted:
How to cite
Pan y Hierro (2026). Creatine in women: what the evidence says and what it does not. https://panyhierro.com/en/strength/women/creatine-in-women/. Updated October 4, 2026.
Citation copied